NEUROVASCULAR ACTIVATION PROTOCOL
LIVE

Serial Number

99139877

Owner

Optimal Man, PLLC

Attorney

Blake P. Hurt

Filing Date

Apr 16, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NEUROVASCULAR ACTIVATION PROTOCOL Trademark

Serial Number: 99139877

NEUROVASCULAR ACTIVATION PROTOCOL is a trademark filed by Optimal Man, PLLC on April 16, 2025. The trademark is classified under Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Optimal Man, PLLC (3 trademarks)

1270 25th Street Place SE, Suite 1
Hickory, NC 28602

Entity Type: 99

Trademark Details

Filing Date

April 16, 2025

Registration Date

Not Registered

Published for Opposition

December 9, 2025

Goods & Services

Medical information services, namely, providing information relating to erectile dysfunction treatment; Healthcare services, specifically in the field of treating erectile dysfunction

Filing History

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 5, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 5, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 5, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 4, 2026 AITU
USE AMENDMENT FILED
Jul 31, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 31, 2026 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 3, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 7, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 27, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 27, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 9, 2025 GNRN
NON-FINAL ACTION E-MAILED
Oct 9, 2025 GNRT
NON-FINAL ACTION WRITTEN
Oct 9, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 8, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2025 NWOS
NEW APPLICATION ENTERED
Apr 16, 2025 NWAP
APPLICATION FILING RECEIPT MAILED
Apr 16, 2025 MAFR